NRX Pharmaceuticals (NRXP)

• Market cap: $117M
• 1 day: 5.23%
• 5 days: -5.01%
• 1 month: 8.42%
• 3 months: 82.95%
• 6 months: 43.75%
• Year to date: 22.9%
• 1 year: 19.7%
• 5 years: -98.67%
• 10 years: -96.65%
• Sector: Healthcare
• Industry: Biotechnology

About: NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Employees: 29